Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-09

Clinical Trial Update: Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating reparixin for efficacy and safety in pancreatic islet auto-transplantation after pancreatectomy for chronic pancreatitis h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Reparixin (reparixin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Pancreatectomy for Chronic Pancreatitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-10-09